MARKET

ICPT

Intercept Pharmaceuticals Inc
ICPT
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-2.1326
2.501
11.06
794,693,354.00
Weekly Report: what happened at ICPT last week (0226-0301)?
Weekly Report · 03/04 09:25
Weekly Report: what happened at ICPT last week (0219-0223)?
Weekly Report · 02/26 09:27
Weekly Report: what happened at ICPT last week (0212-0216)?
Weekly Report · 02/19 09:27
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
Gilead Sciences Inc agreed to acquire CymaBay Therapeutics Inc for $32.50 per share in cash. Gilead's seladelpar for liver disease is a low-risk acquisition, says Baird. The drug has the potential to achieve blockbuster peak annual sales of $800 million.
Benzinga · 02/13 19:05
Weekly Report: what happened at ICPT last week (0205-0209)?
Weekly Report · 02/12 09:25
Weekly Report: what happened at ICPT last week (0129-0202)?
Weekly Report · 02/05 09:27
Weekly Report: what happened at ICPT last week (0122-0126)?
Weekly Report · 01/29 09:25
Weekly Report: what happened at ICPT last week (0115-0119)?
Weekly Report · 01/22 09:26
More

Webull offers Intercept Pharmaceuticals Inc stock information, including NASDAQ: ICPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICPT stock methods without spending real money on the virtual paper trading platform.